June 03, 2025

Plant Diet May Delay Myeloma Precursor Progression

First clinical trial shows high-fiber plant-based diet improves microbiome and may delay MGUS/SMM progression to multiple myeloma.

Conexiant

June 02, 2025

Exercise After Chemotherapy Improves Colorectal Cancer Survival

A long-term clinical trial found that structured exercise after colon cancer treatment improved survival outcomes and reduced recurrence rates, offering evidence to support physical activity as part of survivorship care.

Conexiant

May 30, 2025

Major Medical Societies Issue GLP-1 Nutrition Guidelines

New advisory addresses nutritional challenges and side effects for obesity treatment

Conexiant

May 30, 2025

MASLD During Pregnancy Triples Preterm Birth Risk

Women with biopsy-confirmed MASLD faced triple the risk of preterm birth and higher emergency cesarean rates, even when controlling for obesity and family-related factors.

Conexiant

May 30, 2025

Most Kids with Pancreatitis Miss Diabetes Targets, Study Finds

In a 5-year study, 81% of children with pancreatitis-related diabetes failed to meet blood sugar targets despite routine monitoring and treatment.

Conexiant

May 29, 2025

Physical Disease Clusters Predict Future Depression Risk

A large UK study found that people with multiple physical health conditions face a significantly higher risk of developing depression, with risk levels varying by type and number of conditions.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 28, 2025

GLP-1 Meds Tied to Lower Drinking: Study

"No patient reported an increase in alcohol intake."

Conexiant

May 23, 2025

Patients With Psoriasis Show Inflammation Despite Skin Clearance

Over one-third of psoriasis patients had elevated hs-CRP despite biologic treatment and skin clearance, with obesity, female sex, and fatty liver disease identified as key predictors of residual inflammation.

Conexiant